G G Ž . Objective: N , N -dimethylarginine asymmetric dimethylarginine, ADMA is an important endogenous substance with potent Ž . inhibitory actions on nitric oxide NO synthesis. The present study was designed to determine circulating ADMA levels and Ž . endothelium-dependent, NO mediated vasodilation in a rat model of congestive heart failure CHF . Methods: CHF was induced in rats by coronary artery ligation. Sham-operated rats served as normal controls. Plasma ADMA was determined by high performance liquid Ž . Ž . chromatography with fluorescence detection. Glomerular filtration rate GFR and renal blood flow RBF were measured by the clearance of inulin and p-aminohippuric acid, respectively. Endothelial function of the aorta was assessed in an organ bath. Results: Ž . Plasma levels of ADMA in rats with CHF 0.94 " 0.05 mmolrl were significantly increased compared with sham-operated controls Ž . Ž . 0.75 " 0.06 mmolrl, p -0.05 . Plasma levels of ADMA was negatively correlated with GFR r sy0.65, p -0.05 . Decreased Ž .Ž . endothelium-dependent relaxation to acetylcholine in the aorta of CHF was completely restored by L-arginine 300 mM p -0.01 while endothelium-independent relaxation to nitroprusside was not altered. ADMA potently inhibited endothelium-dependent relaxation in Ž . thoracic aorta of normal and CHF rats. The effect of ADMA was completely antagonized by L-arginine in both groups p -0.01 . Moreover, L-arginine improved endothelium-dependent relaxation in CHF rats in the presence of ADMA. Conclusions: An endogenous NO synthesis inhibitor ADMA is increased in the circulation of rats with CHF. The increased plasma levels of ADMA may contribute to the decreased endothelium-dependent relaxation in CHF, which is restored by L-arginine, possibly by competitive antagonism of ADMA. q 1998 Elsevier Science B.V.
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Introduction

Ž .
Endothelium-derived nitric oxide NO is an important w x mediator involved in the regulation of vascular tone 1,2 . NO is synthesized from L-arginine by nitric oxide synthase Ž . w x NOS 3 . This reaction is competitively inhibited by ( )w x substances 5,6 . In the human circulation, concentrations of dimethylarginines are ten times greater than that of w x L-NMMA 7 . ADMA but not SDMA has been shown to inhibit NO synthesis in vitro and in vivo experiments in w x animals and in man 7 . Furthermore, ADMA dose-dependently inhibits vascular endothelium-dependent relaxations w x 8 . Thus, accumulation of endogenous ADMA has the potential to impair NO synthesis and increase vascular tone.
Ž . Congestive heart failure CHF is associated with inw x creased peripheral vascular resistance 9,10 . This increased vascular resistance in the later stage of CHF is detrimental and may contribute to symptoms and the high mortality of this disease. Although sympathetic and neurohormonal activation contributes significantly to this inw x creased vascular tone 9,11 , endothelial dysfunction also w x plays an important role 12 . Recent studies have shown that CHF is associated with a decreased endothelium-dew x pendent, NO mediated vasodilation 12-15 . However, the mechanisms of the impaired endothelium-dependent relaxation in CHF are not well understood. It is not known if endogenous ADMA plays a role in the impaired endothelial function. In the present study we tested the hypothesis that circulating ADMA levels are increased in a rat model of CHF induced by myocardial infarction. The effects of ADMA on endothelium-dependent relaxation in CHF were determined in the presence and absence of L-arginine. w x Since ADMA is excreted from the urine 7 , the relationship between plasma ADMA and renal function was also studied.
Methods
Experimental animals
The experiments were conducted on male Sprague-Ž . Dawley rats 200-300 g . All animals were maintained on normal rat chow and given water ad libitum in a 12-hour lightrdark cycle. Animals were caged individually after surgical operation. The study protocol was approved by the Council on Animal Care at the University of Western Ontario.
Induction of congestiÕe heart failure
Ž
. During sodium pentobarbital 50 mgrkg, i.p. anaesthesia the rats were intubated and artificially ventilated with a Ž . respirator SAR-830, CWE, Inc., Ardmore, PA . A left thoracotomy was performed, exposing the left side of the heart. The left coronary artery was ligated by positioning a suture between the pulmonary artery out-flow tract and the w x left atrium as previously described 16,17 . The lungs were thereafter hyper-inflated using positive end-expiratory pressure and the thorax immediately closed. After coronary artery ligation 24% died within several hours of the operation. Those surviving this initial period had 12% mortality within 8 weeks, which was similar to a previous report w x 18 . Sham-operated rats underwent the same surgical procedure without coronary artery ligation. Rats were randomly assigned to the following experiments 6-8 weeks after coronary artery ligation or sham-operation. Ž . thermodilution probe 2.5F, Baxter, Mississauga, Ontario was inserted from the right femoral artery so that its tip Ž . was at the aortic arch and another catheter PE-50 was inserted in the superior vena cava via the right jugular vein w x for injection of saline 19 . The tail artery was cannulated for measurements of blood pressure and heart rate. Catheters were tunnelled subcutaneously to an exit site between the scapulae. Experiments were performed in conscious animals 2-3 h after surgery. Pressures and heart rate were measured by using a Hewlett-Packard pressure Ž . transducer model 1290A connected to a pressure monitor Ž . and recorded on a Gould recorder model 2400S . CO was Ž measured by a cardiac computer American Edwards Lab-. oratories, CA by injection of 0.2 ml saline at 21-228C and the average of triplicate measurements was taken.
Hemodynamic monitoring in conscious rats
Ž . Ž . Cardiac index CI s COrbody weight mlrminr100 g .
Measurement of glomerular filtration rate and renal blood flow
During pentobarbital anaesthesia, the left carotid artery and vein were cannulated. The abdomen was incised and the bladder was cannulated for urine collection. The rats Ž . n s 5 in each group were infused intravenously with a Ž . solution of 10% inulin Eastman Chemical Co and 0.25% Ž . Ž . p-aminohippuric acid PAH Sigma in normal saline at a rate of 1.5 mlrh. After approximately 60 min of equilibration, urine samples were collected under oil in preweighed Ž vials for 3 sequential 20 min periods. Blood samples 150 . ml were obtained at the midpoint of each clearance period. Urine volume was calculated gravimetrically. Hematocrit was calculated by the microcapillary tube method. Urine and plasma samples were assayed for inulin and PAH by standard colorimetric methods. Glomerular filtra-Ž . Ž . tion rate GFR and renal blood flow RBF were calcuw x lated as the clearance of inulin and PAH, respectively 20 . At the end of the experiment, the rat was euthanized with an over-dose pentobarbital, and the kidney was removed, decapsulated, cut in half, blotted dry, and weighed. GFR and RBF were expressed as per gram kidney weight. At the end of the last clearance period, 5 ml of blood were drawn for measurement of plasma ADMA levels.
Determination of plasma ADMA and concentrations
The rats were anaesthetized with sodium pentobarbital Ž . Ž . 50 mgrkg, i.p. . Blood 5 ml drawn from carotid artery was collected into heparinised tubes and centrifuged at 2500 g for 15 min to separate plasma. All plasma samples were kept at y708C until analysis.
Ž . Ž . Samples from CHF n s 10 and Sham rats n s 10 were analyzed using high-performance liquid chromatogra-Ž . phy HPLC and fluorescence detection, a method recently w x developed in our laboratory 21 . Briefly, ADMA and SDMA were extracted from the plasma samples with a Ž . cation exchange column, Isolute-SCX 100 mg . The column was activated with 1 ml methanol, conditioned with 2 Ž . ml TCA 2% and applied with 1.5 ml plasma. The column Ž . was subsequently rinsed with 1 ml TCA 2% , 3 ml Ž . phosphate buffer pH 8 and 1 ml methanol. ADMA and SDMA were eluted in 2 ml methanol containing 30% distilled water and 2% fresh triethylamine prepared daily. The eluent was then evaporated to dryness at 608C under nitrogen. The dried extract was dissolved in distilled water and passed through a 0.22 mm filter. ADMA and SDMA were converted to fluorescent derivatives with o-phthalaldehyde in an alkaline medium and separated on a 3 mm Ž . Ž . Ž Ultracarb 3 ODS 20 150 = 4.6 mm column Phenome-. nex, Torrance, CA, USA with a multigradient elution. A Ž Waters 420-AC fluorescence detector Millipore Co, Mil-. ford, MA with a 338 nm bandpass excitation filter, and a 425 nm longpass emission filter and a flow cell of 8 ml was used for detection. The recoveries of ADMA and SDMA were over 80% and the detection limit was 0.2 mmolrl.
Assessment of Õascular endothelial function in Õitro
Thoracic aortae were isolated and cut into rings ; 3 mm in length. Aortic rings were mounted between two stainless steel wires in 5 ml organ baths containing Krebs Ž solution in mM: 118 NaCl, 4.7 KCl, 2.5 CaCl , 1.2 2 MgSO P H O, 1.2 K PO , 11 dextrose, and 22 NaHCO ; determined as the optimal resting tension during preliminary investigation, was applied to the aortic rings. One wire was fixed to a brass manipulator and the other was Ž attached to a FTO3 isometric force transducer Grass . Instruments, Quincy, MA and a Grass model 79E polygraph for the continuous recording of tension. The contractile capacity of each vessel segment was examined by . glandin F PGF , 10 to 3 = 10 M was assessed in 2 a 2 a Ž . Ž . CHF n s 5 and Sham n s 4 rats. In the subsequent experiments, all vessels were preconstricted with PGF 2 a Ž y5 . 10 M and endothelium-dependent relaxation was assessed with increasing concentrations of acetylcholine Ž y9 y5 . 10 -10 M . Endothelium-independent relaxation was assessed with increasing concentrations of nitroprusside Ž y10 y7 . 10 -10 M .
Ž . Ž . In CHF n s 8 and Sham rats n s 7 , after control responses to acetylcholine and nitroprusside were obtained, Ž . the vessels were treated with L-arginine 300 mM in the organ bath for 15 min. The assessment of relaxations to acetylcholine and nitroprusside was repeated in the pres-Ž . ence of L-arginine 300 mM , a concentration which has w x been shown to inhibit the effects of ADMA in vitro 7 . In Ž . normal control rats n s 12 , responses to acetylcholine and nitroprusside were assessed in the presence and ab-Ž . 
Measurement of infarct size
The heart was dissected out, weighed and cut into four transverse slices of equal thickness. Photographs were taken for each heart slice. The endocardial circumferences of fibrotic and normal areas were quantitated with a distance meter. Infarct size was expressed as a fraction of the total cross-sectional circumference of the left ventricle w x 16,17 .
Data analysis
Data are expressed as mean " SEM. EC values were 50 calculated by GraphPad Prism computer program using non-linear sigmoid curve fitting and are expressed as 
Ž . ylog M . Unpaired Student's t-test or two-way analysis
Ž . of variance ANOVA followed by unpaired Student's t-test and linear regression were used. Two-tailed p value -0.05 was considered statistically significant.
Results
General characteristic of CHF
Ž
. The infarct size of coronary artery ligated rats n s 24 Ž . was 40.8 " 1.5% of the left ventricle Table 1 . No myocardial infarction was observed in sham-operated control Ž . rats n s 22 . In CHF, the weight of the heart, heart to body weight ratio, left and right ventricles were signifi-Ž cantly increased compared to sham-operated rats p -. 0.01 . Cardiac index and developed pressures of the left ventricle were decreased while left ventricular end-diastolic pressure and total peripheral resistance were signifi-Ž . Ž . cantly increased in CHF rats p -0.05 see Table 1 . These hemodynamic changes in coronary artery ligated rats formed a picture characteristic of clinical congestive heart failure.
Plasma ADMA in CHF
Plasma levels of ADMA in rats with CHF were significantly increased by 25.3% compared to sham-operated Ž .Ž . controls p -0.05 Fig. 1 . Plasma levels of SDMA were 0.39 " 0.04 and 0.38 " 0.03 mmolrl in CHF and sham Ž . rats, respectively p s n.s. . The ADMArSDMA ratio Ž . was slightly higher in CHF 2.48 " 0.15 compared with Ž . sham-operated rats 2.10 " 0.22 , but not statistically sig-Ž . nificant p s 0.18 .
Correlation between GRF and ADMA
GFR and RBF were measured in 5 CHF and 5 sham-operated rats which also had plasma ADMA measurements. Ž Both GFR and RBF were similar between CHF 1.01 " . 0.09 and 6.78 " 0.56 mlrminrg kidney weight and In aortic rings, endothelium-dependent relaxation to Ž . acetylcholine was significantly decreased in CHF n s 8 Ž .Ž compared to sham-operated rats n s 7, p -0.01 Table  . 2, Fig. 3 . EC of acetylcholine was significantly in-50 Ž creased in CHF compared with sham-operated rats p -Ž . Fig. 6 . Effect of asymmetric dimethylarginine ADMA, 300 mM on endothelium-dependent relaxation to acetylcholine and endothelium-independent relaxation to nitroprusside in the aorta of congestive heart failure Ž . Ž . rats ns 5 in the presence and absence of L-arginine 300 mM .
. 0.01 . However, endothelium-independent relaxation to nitroprusside was not different between CHF and sham-oper-Ž . Ž . ated rats p s n.s. Fig. 3 , Table 2 . With L-arginine treatment, the decreased endothelium-dependent relaxation to acetylcholine in CHF was restored to the response Ž .Ž . similar to sham-operated rats p -0.01 Fig. 4 , Table 2 . L-arginine did not alter endothelium-dependent relaxation to acetylcholine in Sham rats or relaxation to nitroprusside Ž .Ž . in both CHF and Sham rats p s n.s. Fig. 4, Table 2 .
In order to see if ADMA contributes to decreased endothelium-dependent relaxation, aortic rings were treated with increasing concentrations of ADMA. In normal control animals, ADMA showed concentration-dependent inhibition of endothelium-dependent relaxation to acetyl-Ž . choline p -0.01 with no effects on endothelium-inde-Ž .Ž pendent relaxation to nitroprusside p s n.s. Fig. 5 , Table  . Ž . 3 . The effect of ADMA 300 mM was completely re-Ž .Ž . stored by L-arginine 300 mM . Ž . Table 3 . Moreover, L-arginine 300 mM shifted the acetylcholine response curve to the right of CHF control Ž . Ž response p -0.05 in the presence of ADMA Fig. 6 , . Table 3 . Neither L-arginine nor ADMA changed the re-Ž . Ž sponse to nitroprusside in CHF p s n.s. Fig. 6 , Table  . 3 .
Discussion
Endothelium-dependent, NO-mediated vascular relaxation is decreased in CHF. Decreased endothelium-dependent relaxation has been documented in the peripheral w x arteries of a pacing-induced CHF dog model 14 , and in thoracic aorta and hindquarter resistance arteries in a CHF w x rat model induced by myocardial infarction 12,13 . Smith and co-workers have demonstrated a reduced mRNA and protein expression of endothelial NOS in the pacing-inw x duced CHF dog model 22 . We have recently demonstrated that constitutive NOS activity is decreased in the w x aortae of CHF rats 23 . However, the mechanism of the decreased endothelium-dependent relaxation and NOS exw x pression is not fully understood 22 . CHF is associated w x with increased production of cytokines 24,25 that have been shown to downregulate endothelial NOS mRNA exw x pression 26 . Pulsatility is believed to be a potent stimulus w x for NO 27 , which may be decreased in CHF due to decrease in cardiac output and vascular blood flow. In addition, increased oxidative stress may also play a role in the decreased endothelium-dependent relaxation in CHF, w x as oxygen free radicals may inactivate NO 28 . In the present study, we demonstrate for the first time that an endogenous NO synthesis inhibitor ADMA is increased in the circulation of rats with CHF. Since ADMA inhibits ( )endothelium-dependent relaxation in a concentration-dependent manner, the increased plasma levels of ADMA may be one of the factors that contribute to the decreased endothelium-dependent relaxation and NO production in CHF. w x ADMA is a major endogenous NOS inhibitor 7,29 . Previous studies have shown that ADMA inhibits NO w x production and endothelium-dependent relaxation 8 . This is confirmed in the present study in normal control and CHF rats. Furthermore, we demonstrated that the inhibitory effects of ADMA on endothelium-dependent relaxation were completely restored by L-arginine, indicating the balance between L-arginine and ADMA is important in normal endothelial function. In rats with CHF, plasma levels of ADMA were increased. Since methylarginines w x are concentrated within the cell 30 , a moderate increase Ž . 25.3% in plasma ADMA concentration in CHF rats as observed in the present study may mirror a much higher increase of the compound in the vicinity of the NO synthase and thus results in decreased endothelium-dependent relaxation in CHF. ADMArSDMA ratio has been demonstrated to be increased in patients with chronic renal failure w x 7,29 . In the present study, ADMArSDMA ratio was not significantly increased in CHF rats. Since SDMA does not affect endothelial function, the ADMArL-arginine ratio rather than ADMArSDMA ratio might be a better index for endothelial function. In this regard, we have recently measured plasma L-arginine level and found it was de-Ž . creased in CHF rats unpublished observations . These data and the results from the present study suggest an increased ADMArL-arginine ratio and thus nitric oxide synthase inhibition in CHF.
L-Arginine has been demonstrated to improve endothelial function in vivo by several investigators. Hirooka and co-workers showed intra-arterial L-arginine administration improves endothelium-dependent and ischemic vasodilaw x tion in the forearm of patients with CHF 31 . Furthermore, acute L-arginine treatment has beneficial hemodynamic w x effects in pulmonary hypertension 32 , and short-term oral supplementation of L-arginine improves functional status w x in patients with CHF 33 . However, the exact mechanisms of the effects of L-arginine are not clear. Although administration of L-arginine has been demonstrated to increase w x NO production 34 , the release of insulin and pituitary growth hormone may also mediate the effects of L-arginine w x in vivo 35,36 . In the present study, acute L-arginine Ž . treatment in organ bath in a concentration 300 mM that is very close to the normal physiological levels of plasma Ž . w x L-arginine 200 mM in rats 37 restored endothelium-dependent relaxation in the aorta of rats with CHF. Since L-arginine treatment in vitro is not likely to cause release of insulin and growth hormones in the aortic rings, the results support the notion that L-arginine antagonizes the inhibitory effect of ADMA in the vicinity of the NO synthase, which may be increased in CHF, and thus improves endothelial function.
ADMA is synthesized by methylation of arginine residues in proteins and subsequent hydrolysis of the argiw x nine residues in proteins 38 . Thus the amounts of ADMA produced may reflect rates of protein methylation and degradation. The removal of ADMA might occur by metabolism or excretion. Rat kidney contains dimethw x ylarginase that metabolizes ADMA to citrulline 39 . Human endothelial cells possess an enzyme that has similar w x properties to dimethylarginase 30 . Impairment in this metabolizing pathway would also increase dimethylarginine concentrations. A recent study demonstrated that ADMA is increased in the regenerated endothelial cells 6 weeks after endothelium denudation, and may contribute to decreased endothelium-dependent relaxation in the enw x dothelial damaged vessels 8 . Whether ADMA is increased in the vascular endothelial cells in CHF requires further investigation.
In the present study, measurements of GFR and RBF in rats with CHF were similar with those of sham-operated control animals. The results suggest that the renal function is well preserved at basal conditions in these CHF rats. Our results are consistent with a previous study showing that GFR and RBF are normal in rats with infarct size w x 10-40% of the left ventricle 40 . Even in rats with infarcts greater than 40%, GFR and RBF show only mild reduc-Ž . tions of borderline significance p s 0.053 under basal w x conditions 40 . However, rats with infarcts 10-40% exhibit a distinct impairment in their ability to excrete sodium w x in response to an acute sodium load 40,41 . A significant correlation between plasma ADMA levels and GFR observed in the present study supports the notion that enw x dogenous ADMA is excreted in the urine 7 . Since basal GFR and RBF are not altered, it is possible that urinary excretion of ADMA may be normal in these CHF animals. However, it is not known whether there are changes in ADMA production andror metabolism in CHF. Therefore, the exact mechanisms of increased circulating levels of ADMA in CHF require further investigation.
A major limitation of the present study is that we did not measure ADMA concentrations within the endothelial cells or tissue levels in the aorta. Although our HPLC method is highly sensitive for plasma ADMA measurements, it is not possible to determine intracellular or tissue levels of ADMA in the aorta due to the limited number of cells or tissues we could harvest from a rat. Therefore, a more sensitive assay is needed to measure directly endothelial as well as tissue ADMA levels in CHF rats.
In summary, ADMA an endogenous NO synthesis inhibitor is increased in the circulation of rats with CHF. ADMA inhibits endothelium-dependent relaxation in both normal and CHF rats. This effect of ADMA is completely antagonized by L-arginine. Furthermore, in vitro L-arginine treatment restores endothelium-dependent relaxation in CHF rats. We therefore conclude that the increased plasma levels of ADMA may contribute to the decreased endothelium-dependent relaxation in CHF. 
